NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 66,344 Value ($000) $105 Avg Close — Range —
Q4 2023
Shares 64,866 Value ($000) $56 Avg Close — Range —
Q3 2023
Shares 64,866 Value ($000) $69 Avg Close — Range —
Q2 2023
Shares 62,055 Value ($000) $161 Avg Close — Range —
Q1 2023
Shares 55,692 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 54,707 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 54,166 Value ($000) $708 Avg Close — Range —
Q2 2022
Shares 49,917 Value ($000) $640 Avg Close — Range —
Q1 2022
Shares 39,806 Value ($000) $607 Avg Close — Range —
Q4 2021
Shares 42,526 Value ($000) $753 Avg Close — Range —
Q3 2021
Shares 42,937 Value ($000) $903 Avg Close — Range —
Q2 2021
Shares 40,830 Value ($000) $805 Avg Close — Range —
Q1 2021
Shares 28,492 Value ($000) $828 Avg Close — Range —
Q4 2020
Shares 29,352 Value ($000) $889 Avg Close — Range —
Q3 2020
Shares 27,475 Value ($000) $437 Avg Close — Range —
Q2 2020
Shares 31,591 Value ($000) $624 Avg Close — Range —
Q1 2020
Shares 26,395 Value ($000) $325 Avg Close — Range —
Q4 2019
Shares 23,456 Value ($000) $434 Avg Close — Range —